Bibliography
Smith, C. J., Gali, H., Sieckman, G. L., Hayes, D. L., Owen, N. K., Mazuru, D. G., Volkert, W. A., & Hoffman, T. J. (2003). Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nuclear Medicine and Biology, 30(2), 101â109.
References
41
Referenced
80
10.1021/cr980451q
/ Chem. Rev. / Radiometal-labeled agents (non-technetium) for diagnostic imaging by Anderson (1999)10.1021/bc9701959
/ Bioconjugate Chem. / Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues by Baidoo (1998)10.1016/0024-3205(91)90052-D
/ Life Sci. / [Indium-111-DTPA-D-Phe-1]octreotide, a potential radiopharmaceutical for imaging somatostatin receptor positive tumors by Bakker (1991){'key': '10.1016/S0969-8051(02)00391-8_BIB4', 'first-page': '834', 'article-title': 'Improved prospects for cancer therapy with radiolabeled antibody fragments and peptides?', 'volume': '37', 'author': 'Behr', 'year': '1996', 'journal-title': 'J. Nucl. Med.'}
/ J. Nucl. Med. / Improved prospects for cancer therapy with radiolabeled antibody fragments and peptides? by Behr (1996){'key': '10.1016/S0969-8051(02)00391-8_BIB5', 'first-page': '4', 'article-title': 'Selective drug delivery by means of receptor-mediated endocytosis', 'volume': '39', 'author': 'Bijsterbosch', 'year': '1995', 'journal-title': 'Q. J. Nucl. Med.'}
/ Q. J. Nucl. Med. / Selective drug delivery by means of receptor-mediated endocytosis by Bijsterbosch (1995)10.1053/snuc.2000.7441
/ Sem. Nucl. Med. / Radio-labeled receptor-binding peptides by Boerman (2000)10.1021/ic00236a024
/ Inorg. Chem. / Synthesis of 1-(p-Isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies by Brechbiel (1986)10.1002/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y
/ Int. J. Cancer / Pre-clinical evaluation of [111In-DTPA-Pro1, Tyr4]Bombesin, a new radioligand for bombesin-receptor scintigraphy by Breeman (1999)10.1002/(SICI)1097-0215(19990517)81:4<658::AID-IJC24>3.0.CO;2-P
/ Int. J. Cancer / Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy by Breeman (1999)10.1021/cr980440x
/ Chem. Rev. / Gadolinium(III) chelates as MRI contrast agents by Caravan (1999)10.1089/cbr.2000.15.531
/ Cancer Biotherapy & Radiopharm. / Current and potential therapeutic uses of lanthanide radioisotopes by Cutler (2000)10.1007/s002590050064
/ Eur. J. Nucl. Med. / Yttrium-90 and Indium-111 labeling, receptor binding, and biodistribution of [DOTA0-D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy by deJong (1997){'key': '10.1016/S0969-8051(02)00391-8_BIB13', 'series-title': 'Nuclear imaging in drug discovery, development, and approval', 'article-title': 'The design of site-directed radiopharmaceuticals for use in drug discovery', 'author': 'Eckelman', 'year': '1993'}
/ Nuclear imaging in drug discovery, development, and approval / The design of site-directed radiopharmaceuticals for use in drug discovery by Eckelman (1993){'issue': 'Suppl 5', 'key': '10.1016/S0969-8051(02)00391-8_BIB14', 'first-page': '119', 'article-title': 'In vitro and in vivo evaluation of 111In-labeled DOTA-8-Aoc-BBN[7-14]NH2 conjugate for specific targeting of tumors expressing gastrin releasing peptide receptors (GRP-R)', 'volume': '41', 'author': 'Gali', 'year': '2000', 'journal-title': 'J. Nucl. Med.'}
/ J. Nucl. Med. / In vitro and in vivo evaluation of 111In-labeled DOTA-8-Aoc-BBN[7-14]NH2 conjugate for specific targeting of tumors expressing gastrin releasing peptide receptors (GRP-R) by Gali (2000)10.1073/pnas.95.22.12814
/ Proc. Natl. Acad. Sci. U. S. A. / Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination by Giblin (1998)10.1021/ar980002c
/ Acc. Chem. Res. / The role of inorganic chemistry in the development of radiometal agents for cancer therapy by Heeg (1999){'key': '10.1016/S0969-8051(02)00391-8_BIB17', 'author': 'Hoffman', 'year': '2001', 'journal-title': 'J. Nucl. Med.'}
/ J. Nucl. Med. by Hoffman (2001){'key': '10.1016/S0969-8051(02)00391-8_BIB18', 'first-page': '490', 'article-title': 'Synthesis and characterization of 105Rh labeled bombesin analogues', 'volume': '40', 'author': 'Hoffman', 'year': '1997', 'journal-title': 'J. Labelled Compd. Radiopharm.'}
/ J. Labelled Compd. Radiopharm. / Synthesis and characterization of 105Rh labeled bombesin analogues by Hoffman (1997)10.1016/S0969-8051(01)00209-8
/ Nucl. Med. Biol. / Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells by Hoffman (2001)10.1016/S0969-8051(97)00066-8
/ Nucl. Med. Biol. / Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals by Hom (1997)10.1021/bc980096a
/ Bioconjugate Chem. / 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent by Karra (1999){'key': '10.1016/S0969-8051(02)00391-8_BIB22', 'series-title': 'Technetium, rhenium and other metals in chemistry and nuclear medicine', 'first-page': '153', 'article-title': 'Somatostatin receptor imaging of neuroendocrine carcinomas', 'author': 'Kvols', 'year': '1999'}
/ Technetium, rhenium and other metals in chemistry and nuclear medicine / Somatostatin receptor imaging of neuroendocrine carcinomas by Kvols (1999)10.1007/s002590100574
/ Eur. J. Nucl. Med. / [177Lu-DOTA0,Tyr3]octreotate by Kwekkeboom (2001)10.1002/ijc.1540
/ Int. J. Cancer / Toxicity and dosimetry of 177Lu-DOTA-Y3-Octreotate in a rat model by Lewis (2001){'key': '10.1016/S0969-8051(02)00391-8_BIB25', 'first-page': '105', 'article-title': '[Psi13,14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo', 'volume': '37', 'author': 'Mahmoud', 'year': '1985', 'journal-title': 'Life Sci.'}
/ Life Sci. / [Psi13,14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo by Mahmoud (1985){'issue': '5', 'key': '10.1016/S0969-8051(02)00391-8_BIB26', 'first-page': '1152', 'article-title': 'Gastrin-releasing peptide receptors in the human prostate', 'volume': '59', 'author': 'Markwalder', 'year': '1999', 'journal-title': 'Cancer Res'}
/ Cancer Res / Gastrin-releasing peptide receptors in the human prostate by Markwalder (1999){'key': '10.1016/S0969-8051(02)00391-8_BIB27', 'first-page': '426', 'article-title': 'Pharmacokinetic studies of 105Rh(III) Complexes with macrocycles', 'volume': '37', 'author': 'Ning', 'year': '1995', 'journal-title': 'J. Labelled Compd. Radiopharm.'}
/ J. Labelled Compd. Radiopharm. / Pharmacokinetic studies of 105Rh(III) Complexes with macrocycles by Ning (1995){'key': '10.1016/S0969-8051(02)00391-8_BIB28', 'first-page': '1', 'article-title': 'Radiolabeled antibody therapy of lymphomas', 'volume': '4', 'author': 'Press', 'year': '1994', 'journal-title': 'Biol. Ther. Cancer Update'}
/ Biol. Ther. Cancer Update / Radiolabeled antibody therapy of lymphomas by Press (1994){'key': '10.1016/S0969-8051(02)00391-8_BIB29', 'first-page': '1035', 'article-title': 'Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro', 'volume': '54', 'author': 'Qin', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro by Qin (1994)10.1002/ijc.2910630219
/ Int. J. Cancer / Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP by Qin (1995){'key': '10.1016/S0969-8051(02)00391-8_BIB31', 'series-title': 'Technetium, rhenium and other metals in chemistry and nuclear medicine', 'first-page': '519', 'article-title': 'In vitro binding and internalization of an Indium-111 labeled bombesin derivative to cells expressing the gastrin releasing peptide receptor', 'author': 'Rogers', 'year': '1999'}
/ Technetium, rhenium and other metals in chemistry and nuclear medicine / In vitro binding and internalization of an Indium-111 labeled bombesin derivative to cells expressing the gastrin releasing peptide receptor by Rogers (1999)10.1002/(SICI)1097-0142(19971215)80:12+<2419::AID-CNCR13>3.0.CO;2-F
/ Cancer Suppl. / Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector by Rogers (1997)10.1007/s002590050267
/ Eur. J. Nucl. Med. / Radionuclide imaging of neuroendocrine tumors by Seregni (1998)10.1021/bc950097s
/ Bioconjugate Chem. / Vehicles, chelators, and radionuclides by Schubiger (1996){'key': '10.1016/S0969-8051(02)00391-8_BIB35', 'article-title': 'Radiochemical investigations of 99mTc-N3S-X-BBN[7-14]NH2', 'author': 'Smith', 'year': '2001', 'journal-title': 'Bioconjugate Chem.'}
/ Bioconjugate Chem. / Radiochemical investigations of 99mTc-N3S-X-BBN[7-14]NH2 by Smith (2001)10.1002/jlcr.25804401249
/ J. Labelled Compd. Radiopharm. / Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2 by Smith (2001){'key': '10.1016/S0969-8051(02)00391-8_BIB37', 'first-page': '967', 'article-title': 'Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7', 'volume': '42', 'author': 'Stein', 'year': '2001', 'journal-title': 'J. Nucl. Med.'}
/ J. Nucl. Med. / Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7 by Stein (2001)10.1016/0969-8051(95)02001-2
/ Nucl. Med. Biol. / Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma by Ugur (1996){'key': '10.1016/S0969-8051(02)00391-8_BIB39', 'first-page': '21', 'article-title': '99mTc-RP-527, a gastrin releasing peptide (GRP) analogue for visualization of GRP receptor expressing malignancies', 'volume': '21', 'author': 'Van de Wiele', 'year': '2000', 'journal-title': 'Nucl. Med. Commun.'}
/ Nucl. Med. Commun. / 99mTc-RP-527, a gastrin releasing peptide (GRP) analogue for visualization of GRP receptor expressing malignancies by Van de Wiele (2000)10.1007/s002590000355
/ Eur. J. Nucl. Med. / Technetium-99m RP525, a GRP analogue for visualization of GRP receptor-expressing malignancies by Van de Wiele (2000)10.1021/cr9804386
/ Chem. Rev. / Therapeutic radiopharmaceuticals by Volkert (1999)
Dates
Type | When |
---|---|
Created | 22 years, 4 months ago (April 4, 2003, 9:45 p.m.) |
Deposited | 6 years, 5 months ago (March 27, 2019, 1:23 a.m.) |
Indexed | 11 months, 3 weeks ago (Sept. 11, 2024, 5:04 a.m.) |
Issued | 22 years, 7 months ago (Feb. 1, 2003) |
Published | 22 years, 7 months ago (Feb. 1, 2003) |
Published Print | 22 years, 7 months ago (Feb. 1, 2003) |
@article{Smith_2003, title={Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells}, volume={30}, ISSN={0969-8051}, url={http://dx.doi.org/10.1016/s0969-8051(02)00391-8}, DOI={10.1016/s0969-8051(02)00391-8}, number={2}, journal={Nuclear Medicine and Biology}, publisher={Elsevier BV}, author={Smith, C.Jeffrey and Gali, Hariprasad and Sieckman, Gary L. and Hayes, Donald L. and Owen, Nellie K. and Mazuru, Dana G. and Volkert, Wynn A. and Hoffman, Timothy J.}, year={2003}, month=feb, pages={101–109} }